BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Revenue

BioXcel Therapeutics had revenue of $206.00K in the quarter ending March 31, 2026, with 22.62% growth. This brings the company's revenue in the last twelve months to $680.00K, down -63.28% year-over-year. In the year 2025, BioXcel Therapeutics had annual revenue of $642.00K, down -71.67%.

• Revenue (ttm): $680.00K
• Revenue Growth: -63.28%
• P/S Ratio: 58.58
• Revenue / Employee: $23,448
• Employees: 29
• Market Cap: 38.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	642.00K	-1.62M	-71.67%
Dec 31, 2024	2.27M	886.00K	64.20%
Dec 31, 2023	1.38M	1.01M	268.00%
Dec 31, 2022	375.00K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error